Results 251 to 260 of about 4,586,589 (282)
Some of the next articles are maybe not open access.
[Anti-Amyloid Antibody Therapy for Alzheimer's Disease].
Brain and nerve = Shinkei kenkyu no shinpoAlzheimer's disease (AD) is pathologically characterized by deposition of amyloid plaques (comprising amyloid β [Aβ] protein) and neurofibrillary tangles (comprising tau protein), and neuronal death. Aβ monomers aggregate to form oligomers, protofibrils, and mature fibrils.
Moeko, Shinohara, Kenjiro, Ono
openaire +1 more source
Expert Review of Neurotherapeutics
Alzheimer's disease (AD), the leading cause of dementia, poses a significant burden on patients, caregivers, and healthcare systems worldwide. After two decades of extensive efforts, we are still without significantly effective disease-modifying drugs for AD.
Lozupone, Madia +14 more
openaire +3 more sources
Alzheimer's disease (AD), the leading cause of dementia, poses a significant burden on patients, caregivers, and healthcare systems worldwide. After two decades of extensive efforts, we are still without significantly effective disease-modifying drugs for AD.
Lozupone, Madia +14 more
openaire +3 more sources
Modelling of Anti-amyloid-Beta Therapy for Alzheimer’s Disease
2023Swadesh Pal, Roderick Melnik
openaire +2 more sources
Lecanamab Ushers in a New Era of Anti‐Amyloid Therapy for Alzheimer's Disease
Annals of Neurology, 2023Erik S. Musiek +2 more
openaire +2 more sources
Molecular and Cellular Basis for Anti-Amyloid Therapy in Alzheimer Disease
Alzheimer Disease & Associated Disorders, 2003Sam, Gandy +2 more
openaire +2 more sources
Invited Commentary: Radiologist's Role in Anti-Amyloid Therapy for Alzheimer Disease
RadioGraphics, 2023openaire +2 more sources